BioBrit β Full Portfolio
61 tracked investments Β· listed companies and verified rows first
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders.
BiotechSan Diego, US
Robert Hoffman(Executive Officer)Marco Londei(Executive Officer)Hamza Suria(Executive Officer, Director)Daniel Faga(President, CEO, and Director)Christopher Murphy(CFO)
BoardCarol Gallagher(Director)
Co-investorsFrazier Life SciencesNorwest Venture Partners
Castle Biosciences develops, manufactures and commercializes diagnostic and prognostic molecular tests in areas such as dermatology (melanoma), uveal melanoma, gastroenterology (Barrett's esophagus) and mental health.
BiotechDigital HealthHealthtechMedical DevicesFriendswood, US
Derek Maetzold(Executive Officer, Director)Derek J. Maetzold(Founder, President & Chief Executive Officer)Frank Stokes(Chief Financial Officer)Kristen Oelschlager(Chief Operating Officer)Toby Juvenal(Chief Commercial Officer)Hillary Caruso(Chief of Staff)
Co-investorsIllumina VenturesMountain Group Capital
Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer.
BiotechHealthtechCambridge, US
Co-investorsF-Prime Capital PartnersForesite CapitalOrbiMedvenBio PartnersVivo Capital
Co-investorsNew Enterprise Associates (NEA)
Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.
BiotechHealthtechCarlsbad, US
Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)Alan Fuhrman(Executive Officer)
BoardRobert More(Director)Nina Kjellson(Director)in
Co-investorsAlta PartnersNextech InvestCanaan Partners
BiotechSan Diego, US
Douglas J. Jolly(Founder)inCarlos E. Ibanez(Executive Officer)Robert Anthony Williamson(Director)Troy Wilson(Director)Michael Martin(Director)Nicholas A. Boyle, Ph.D.(Executive Officer, Director)
BiotechHealthtechMedical Devices
Co-investorsDag Ventures
Co-investorsSolas BioVentures
Alta Partners is a venture capital firm that invests in and helps build healthcare and biotechnology companies, backing entrepreneurs developing therapeutics and medical innovations.
BiotechHealthtech
BiotechSan Diego, US
Francois Ferre(Director)Jorge Garces(Executive Officer)Greg Hamilton(Executive Officer, Director)J. Matthew Mackowski(Director)Carin Sandvik(Executive Officer)James Glavin(Director)
Co-investorsVivo Capital
BiotechLa Jolla, US
Quyen Nguyen(Executive Officer, Director)Kaveri Parker(Executive Officer)Brett Berman(Executive Officer, Director)James Schmidt(Executive Officer)
BoardKim Kamdar(Director)Dan Bradbury(Director)in
BiotechPompano Beach, US
Jean Kim(Director)Paul Hawkins(Executive Officer, Director)Terry Vance(Director)Matthew Pauls(Director)Patricio Sepulveda(Executive Officer, Director)in
BoardDaniel Bradbury(Director)in
Co-investorsKeiretsu ForumSofinnova Ventures
Aspen Biosciences develops software tools and applications for drug discovery companies to plan, manage, and execute research programs, including applications for managing the discovery process and integrating target and pathway data.
BiotechHealthtechSaaSSan Diego, US
Attralus develops pan-amyloid removal (PAR) therapeutics β biologics and imaging agents designed to bind and remove toxic amyloid β to treat patients with systemic amyloidosis across all disease types and stages.
BiotechHealthtechSouth San Francisco, US
Jonathan Wall(Executive Officer)Spencer Guthrie(Executive Officer)Mark Timney(Executive Officer, Director)Benson Fong(Executive Officer)Rahul Kakkar(Director)Greg Bell(Executive Officer)
Co-investorsAlpha Wave GlobalvenBio PartnersvenBio Global Strategic
Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Jared Tangney(Executive Officer, Director, Promoter)inRichard Yang(Executive Officer, Director)Edward Kliphuis(Director)
BoardDaniel Bradbury(Director)inLana Ghanem(Director)
Co-investorsAlpha Wave GlobalBeyond CapitalJDRF T1D FundHikma Ventures
BiotechSan Diego, US
Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)
BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities.
Biotech
Co-investorsAtacama Ventures
BiotechMarlborough, US
Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)Anjie Roldan(Executive Officer)Warren R. Clark III(Executive Officer)Charles Larson(Director)
Co-investorsSV Health Investors
Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.
AI & Machine LearningBiotechDeep Tech
Co-investorsDCVC (Data Collective)Tenmile
BiotechSan Diego, US
Ross Bundy(Executive Officer, Director)Kiana Aran(Director)Michael Heltzen(Director)
BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)
Co-investorsSerra Ventures
DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing.
BiotechHealthtechMedical DevicesHighland, US
Mary Gardner(Chief Executive Officer & Founder)inSameer B. Shah(Chief Scientist)Steven Yoelin(Chief Medical Strategist)Dimas Jimenez(Chief Financial Advisor)
BoardDaniel Bradbury(Director)
EcoR1 Capital is an investment firm focused on the biotechnology and life sciences sector.
Biotech
Co-investorsSofinnova Ventures
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
Biotech
Stephanie Tagliatela(Founder)in
Co-investorsARCH Venture PartnersGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision FundVenrock
Co-investorsCota CapitalDecheng Capital
Non-invasive diagnostic tools for detecting and managing chronic diseases such as diabetes.
San Diego, US
John D Gerace(Executive Officer, Director)Craig Misrach(Director)
BoardDan Bradbury(Director)inAndy Sassine(Director)Lynn-Ann Gries(Director)James E. Pinkin(Director)
Co-investorsBootstrap Venture Partners
Genalyte is developing Merlin, an automated diagnostic device that processes blood samples on-site and returns lab results within minutes while the patient waits.
Digital HealthHardwareMedical Devices
Co-investorsClaremont Creek VenturesFusionX VenturesIPD CapitalTEL Venture Capital, Inc.
Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure.
BiotechHealthtechLongevityMedical DevicesBlackfalds
Roger Bergersen(Founder (of predecessor TheraVitae Inc.))Ina Sarel(VP, Research and Development)Kyle Makofka(Chief Restructuring Officer)David Berman(Chief Financial Officer)Angus Jenkins(Director)Don Friesen(Director)
In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.
BiotechConsumerFoodTechHealthtechNashville, US
Randolph Legg(Chief Executive Officer)Scott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)
Co-investorsMountain Group Capital
Intercept Pharmaceuticals is a biopharmaceutical company developing medicines for rare and serious liver diseases, with research centered on Farnesoid X Receptor (FXR) biology for conditions such as severe alcohol-associated hepatitis.
BiotechMedical Devices
Co-investorsAisling CapitalRidgeback Capital
San Diego, US
Samir Damani(Executive Officer, Director)Arthur Roke(Executive Officer)Pratik Patel(Executive Officer)
BoardJean Balgrosky(Executive Officer, Director)inGarrett Vygantas(Director)Jacqueline Kosecoff(Director)
Co-investorsBootstrap Venture Partners
MedExcel Capital (MEC) is a venture capital firm investing in precision health and life sciences companies at company-creation, seed, Series A, and Series B stages.
AI & Machine LearningBiotechHealthtech
A biopharmaceutical company developing medicines across oncology, hematology, neuroscience, immunology, and cardiovascular disease areas.
BiotechHealthtech
Co-investorsAvoro Capital Advisors
Telemynd (Mynd Analytics) provides personalized online therapy and psychiatric care, including individual, couples, and child/adolescent therapy plus medication management, delivered by licensed providers nationwide and accepted through insurance.
Digital HealthHealthtechMental HealthAliso Viejo, US
Paul Buck(Executive Officer)George Carpenter(Executive Officer)Walter Schindler(Director)Richard Turner(Director)Thomas Tierney(Director)
BoardZachary McAdoo(Director)
Co-investorsFusionX Ventures
Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.
Construction TechHealthtechUK, GB
Co-investorsAscension VenturesSignet Healthcare Partners
Ovid develops targeted small molecule therapies aimed at reducing seizures with improved safety and tolerability for people affected by epilepsies and other neurological brain conditions.
BiotechHealthtech
Co-investorsSanofi Ventures
Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria.
BiotechFemTechHealthtechSan Diego, US
Stephanie Culler(Founder/CEO)inStephen Van Dien(Founder/CTO)in
Co-investorsFifty YearsFirst Bight VenturesHemi Ventures, LlcOcampo CapitalY CombinatorDCVC (Data Collective)+1 more
Primmune Therapeutics develops PRTX007, an orally administered, systemically active TLR7 agonist that activates interferon-associated innate immune pathways for use in cancer immunotherapy.
BiotechHealthtechCarlsbad, US
Co-investorsBioRock VenturesSamsara BioCapitalPolaris Partners
ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Larry Mimms(Executive Officer, Director)Magda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)
PTM Therapeutics is a biotech company developing therapeutic antibodies that target Post Translational Modifications (PTMs) to create more disease-specific targets.
Biotech
Co-investorsBioRock Ventures
RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product.
BiotechDeep TechMedical DevicesSan Diego, US
Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy.
Biotech
Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes.
BiotechHealthtechCarlsbad, US
Kirk Hammond(Director)Shawn Swaney(Executive Officer)
BoardRoy Cosan(Director)Pierre Lecocq(Director)Vijay Mahant(Director)Michael Torres(Director)
RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments.
AI & Machine LearningBiotechLaguna Niguel, US
Devan ShahMichelle Lynn Hall
Co-investorsElmehΓΈj VenturesPortal InnovationsService Provider Capital
Samsara Capital is an investment firm that backs the development of therapeutics for patients.
Biotech
Co-investorsModi Ventures
Sensulin is a preclinical biopharmaceutical company developing glucose-responsive insulin therapies for type 1 and type 2 diabetes that aim to reduce hypoglycemia risk and daily injection requirements.
BiotechMedical Devices
Dan Bradbury(Executive Chairman and Co-Founder)inMike Moradi(CEO)in
BoardAnanth AnnapragadainChristopher Rhodesin
Co-investorsCortado Ventures
Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.
ConsumerLongevityWellness & Fitness
Co-investors1315 Capital
Co-investorsMission BiocapitalNext Frontier Capital
Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix.
BiotechDeep TechHealthtech
Robert O. Baratta(Co-founder)Shawn DeLorey(Operations & Corporate Development (inventor of PolyCol))
HealthtechSan Diego, US
Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)
BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)
Co-investorsEssex Woodlands Healthcare Partners
Co-investorsAisling CapitalAvoro Capital AdvisorsDelos CapitalEcoR1 Capital
BiotechSan Diego, US
Harry Gruber(Executive Officer, Director)Thomas Darcy(Executive Officer, Director)Dennis Berman(Executive Officer, Director)Douglas Jolly(Executive Officer)
BoardFaheem Hasnain(Director)Lori Kunkel(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.